2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Brain Neoplasms
3
Medulloblastoma
2
Glioma
2
Diffuse Intrinsic Pontine Glioma
2
Xanthomatosis, Cerebrotendinous
1
Urinary Bladder Neoplasms
1
Recurrence
1
Oligodendroglioma
1
Melanoma
1
Influenza, Human
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Advanced Fallopian Tube Carcinoma
1
Interventions
Influenza Vaccines
16
trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine
2
Vaccines
2
Oseltamivir
2
FluMist
2
Cyclophosphamide
2
ziprasidone
1
vaxigrip
1
thymoglobulin
1
peginterferon alfa-2a
1
influvac
1
fludarabine
1
baloxavir
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Starch
1
Spironolactone
1
Sevelamer
1
SARS-CoV-2 inactivated vaccines
1
Rocuronium
1
Rituximab
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nivolumab
1
Nifedipine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Influenza, Human
×
Diphtheria-Tetanus Vaccine
×
Clear all
NCT03396575
2025-10-29
BRAVO
University of Florida
Phase 1
Terminated
11 enrolled